Clinical Trial Update: Tamoxifen Versus Etoposide After First Recurrence in GBM Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial comparing tamoxifen versus etoposide after first recurrence in glioblastoma multiforme patients is currently recruiting. The sponsor is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme

Drugs mentioned

• Etoposide (Etoposide)
• Tamoxifen (tamoxifen)

Snippet

Sponsor: AHS Cancer Control Alberta | Conditions: Glioblastoma Multiforme | Phase 2 | Status: RECRUITING